• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在癌症诊断与治疗中的应用

MicroRNAs in the Diagnosis and Treatment of Cancer.

作者信息

Mansoori Behzad, Mohammadi Ali, Shirjang Solmaz, Baradaran Behzad

机构信息

a Immunology Research Center , Tabriz University of Medical Sciences , Tabriz , Iran.

b Student Research Committee , Tabriz University of Medical Sciences , Tabriz , Iran.

出版信息

Immunol Invest. 2017 Nov;46(8):880-897. doi: 10.1080/08820139.2017.1377407.

DOI:10.1080/08820139.2017.1377407
PMID:29058545
Abstract

Immune cells are recruited into the tumor microenvironment and regulate anti- and pro-tumor signals. MicroRNAs (miRNAs) markedly control the immune system responses in cancer development. miRNAs that affect the immune system could be interesting targets for immunomodulation against cancer, either through the activation of effector cells or through the down-regulation of regulatory cells. Bioinformatic calculations can predict the immune system and miRNA interactions. In this review, we discuss the most recent studies about miRNA as the main regulator of recruitment and the activation of the immune system in the tumor microenvironment and finally we propose several miRNAs that could serve as therapeutic molecules in the immunotherapy of cancer.

摘要

免疫细胞被招募到肿瘤微环境中,并调节抗肿瘤和促肿瘤信号。微小RNA(miRNA)在癌症发展过程中显著控制免疫系统反应。影响免疫系统的miRNA可能是癌症免疫调节的有趣靶点,无论是通过激活效应细胞还是通过下调调节细胞来实现。生物信息学计算可以预测免疫系统与miRNA的相互作用。在本综述中,我们讨论了关于miRNA作为肿瘤微环境中免疫系统招募和激活的主要调节因子的最新研究,最后我们提出了几种可作为癌症免疫治疗中治疗分子的miRNA。

相似文献

1
MicroRNAs in the Diagnosis and Treatment of Cancer.微小RNA在癌症诊断与治疗中的应用
Immunol Invest. 2017 Nov;46(8):880-897. doi: 10.1080/08820139.2017.1377407.
2
Targeting microRNAs as key modulators of tumor immune response.将微小RNA作为肿瘤免疫反应的关键调节因子进行靶向治疗。
J Exp Clin Cancer Res. 2016 Jun 27;35:103. doi: 10.1186/s13046-016-0375-2.
3
MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.微小RNA:结直肠癌中的新型免疫治疗靶点
World J Gastroenterol. 2016 Jun 21;22(23):5317-31. doi: 10.3748/wjg.v22.i23.5317.
4
Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.微小RNA对免疫细胞的调控及基于微小RNA的癌症免疫治疗
Adv Exp Med Biol. 2022;1385:75-108. doi: 10.1007/978-3-031-08356-3_3.
5
MicroRNAs Reprogram Tumor Immune Response.微小RNA重编程肿瘤免疫反应。
Methods Mol Biol. 2018;1699:67-74. doi: 10.1007/978-1-4939-7435-1_4.
6
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.参与肿瘤攻击和肿瘤免疫逃逸的免疫调节 microRNAs。
J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx034.
7
Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.基于 miRNA 的策略在癌症免疫治疗中的诊断和治疗应用。
Cancer Metastasis Rev. 2018 Mar;37(1):45-53. doi: 10.1007/s10555-017-9716-7.
8
microRNA Therapeutics in Cancer - An Emerging Concept.微小 RNA 治疗癌症——一个新兴概念。
EBioMedicine. 2016 Oct;12:34-42. doi: 10.1016/j.ebiom.2016.09.017. Epub 2016 Sep 20.
9
Emerging microRNAs in cancer diagnosis, progression, and immune surveillance.癌症诊断、进展和免疫监测中的新兴 microRNAs。
Cancer Lett. 2018 Dec 1;438:126-132. doi: 10.1016/j.canlet.2018.09.019. Epub 2018 Sep 17.
10
The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.外泌体携带 microRNAs 在癌症免疫调节中的双重作用。
Int J Mol Sci. 2018 Apr 13;19(4):1183. doi: 10.3390/ijms19041183.

引用本文的文献

1
Unravelling the Mysteries of the Sonic Hedgehog Pathway in Cancer Stem Cells: Activity, Crosstalk and Regulation.揭开癌症干细胞中 Sonic Hedgehog 信号通路的奥秘:活性、相互作用与调控
Curr Issues Mol Biol. 2024 May 29;46(6):5397-5419. doi: 10.3390/cimb46060323.
2
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.用于癌症治疗的免疫原性细胞死亡刺激剂:聚焦于天然化合物。
Cancer Cell Int. 2023 Sep 13;23(1):200. doi: 10.1186/s12935-023-03058-7.
3
MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and Study.
miR-146a恢复可抑制三阴性乳腺癌细胞迁移:一项生物信息学及研究
Adv Pharm Bull. 2022 Aug;12(4):842-849. doi: 10.34172/apb.2022.083. Epub 2021 Oct 6.
4
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.乳腺癌重编程中的代谢途径:非编码 RNA 的新视角。
Cells. 2022 Sep 23;11(19):2973. doi: 10.3390/cells11192973.
5
Purple sweet potato delphinidin-3-rutin represses glioma proliferation by inducing miR-20b-5p/Atg7-dependent cytostatic autophagy.紫甘薯矢车菊素-3-芦丁通过诱导miR-20b-5p/Atg7依赖性细胞静止自噬抑制胶质瘤增殖。
Mol Ther Oncolytics. 2022 Jul 31;26:314-329. doi: 10.1016/j.omto.2022.07.007. eCollection 2022 Sep 15.
6
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.抗微管蛋白药物的耐药性:从长春花生物碱到埃坡霉素
Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019.
7
microRNA-193a-5p Suppresses the Migratory Ability of Human KATO III Gastric Cancer Cells through Inhibition of Vimentin and MMP-9.微小RNA-193a-5p通过抑制波形蛋白和基质金属蛋白酶-9抑制人KATO III胃癌细胞的迁移能力。
Adv Pharm Bull. 2022 Jan;12(1):169-175. doi: 10.34172/apb.2022.018. Epub 2020 Oct 19.
8
MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.miR-495 通过靶向 ATP7A 抑制食管癌顺铂耐药和血管生成。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039127. doi: 10.1177/15330338211039127.
9
Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes.加深对胃肠道间质瘤生物学的理解,作为开发新诊断和治疗方案的一个步骤。
Oncol Lett. 2021 May;21(5):417. doi: 10.3892/ol.2021.12678. Epub 2021 Mar 28.
10
HMGA2 as a Critical Regulator in Cancer Development.HMGA2 作为癌症发展中的关键调控因子。
Genes (Basel). 2021 Feb 13;12(2):269. doi: 10.3390/genes12020269.